Citation Impact
77 standout
Citing Papers
Dendritic Cells in Cancer Immunology and Immunotherapy
2024 Standout
Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522
2024 Standout
Works of Diego Kaen being referenced
LBA15 Primary results from IMpassion131, a double-blind placebo-controlled randomised phase III trial of first-line paclitaxel (PAC) ± atezolizumab (atezo) for unresectable locally advanced/metastatic triple-negative breast cancer (mTNBC)
2020
Author Peers
| Author | PRM | Molecular Biology | Oncology | Cancer Research | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Diego Kaen | 42 | 24 | 84 | 27 | 11 | 112 | |
| Gautam Kumar Meghwanshi | 2 | 304 | 12 | 4 | 17 | 404 | |
| Florence D. DiGennaro Reed | 3 | 84 | 2.0k | ||||
| Ming-Feng Hung | 14 | 277 | |||||
| Xiaoxi Zhu | 13 | 403 | |||||
| Chris Rosinger | 2 | 61 | 11 | 2 | 4 | 326 |
All Works
Loading papers...